熱門資訊> 正文
Voyager Therapeutics任命Nathan Jorgensen为CFO
2024-06-13 19:22
- Voyager Therapeutics (NASDAQ:VYGR) announces the appointment of Nathan Jorgensen as CFO, effective July 8, 2024.
- Jorgensen most recently served as CFO for Vor Biopharma Inc. (VOR).
More on Voyager Therapeutics
- Voyager: Alzheimer's Clinical Trial Start (VY-TAU01) Strengthens Investment Thesis
- Voyager Therapeutics up 8% following quarterly beats
- Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M
- Seeking Alpha’s Quant Rating on Voyager Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
